Search Results - Durigova, Anna

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection

    Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection by Viala, Marie, Vinches, Marie, Alexandre, Marie, Mollevi, Caroline, Durigova, Anna, Hayaoui, Nadia, Homicsko, Krisztian, Cuenant, Alice, Gongora, Céline, Gianni, Luca, Tosi, Diego

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    407 Stereotactic magnetic resonance-guided online adaptive radiotherapy in kidney oligometastases

    407 Stereotactic magnetic resonance-guided online adaptive radiotherapy in kidney oligometastases by Laouiti, Mohamed, Mazouni, Zohra, Salati, Emanuela, Durigova, Anna

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Iron homeostasis and anemia markers in early breast cancer

    Iron homeostasis and anemia markers in early breast cancer by Lamy, Pierre-Jean, Durigova, Anna, Jacot, William

    Published in Clinica chimica acta
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

    PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy by Jacot, William, Dalenc, Florence, Lopez-Crapez, Evelyne, Chaltiel, Leonor, Durigova, Anna, Gros, Nathalie, Lozano, Nicolas, Lacaze, Jean-Louis, Pouderoux, Stéphane, Gladieff, Laurence, Romieu, Gilles, Roché, Henri, Filleron, Thomas, Lamy, Pierre-Jean

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study

    Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multi... by Dell'Ova, Mélodie, De Maio, Eléonora, Guiu, Séverine, Roca, Lise, Dalenc, Florence, Durigova, Anna, Pinguet, Frédéric, Bekhtari, Khedidja, Jacot, William, Pouderoux, Stéphane

    Published in BMC cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Abstract P5-21-02: Final results of the VitaCal randomized phase III study evaluating the impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients

    Abstract P5-21-02: Final results of the VitaCal randomized phase III study evaluating the impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D l... by Jacot, William, Firmin, Nelly, Roca, Lise, Topart, Delphine, Gallet, Sophie, Durigova, Anna, Mirr, Simone, Pouderoux, Stéphane, Bleuse, Jean-Pierre, Lamy, Pierre-Jean, Romieu, Gilles

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Abstract P4-07-08: Circulating miRNAs as surrogate markers for hormonosensibility in patients with hormone receptor-positive metastatic breast cancer? A pilot study

    Abstract P4-07-08: Circulating miRNAs as surrogate markers for hormonosensibility in patients with hormone receptor-positive metastatic breast cancer? A pilot study by Dalenc, Florence, Ouali, Monia, Filleron, Thomas, Gladieff, Laurence, Roché, Henri, Lacaze, Jean-Louis, Jacot, William, Durigova, Anna, Pradines, Anne, Bringer, Pauline, Farella, Magali, Favre, Gilles

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: